CoChat

Neutralizing IL-17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation

Open access
Fan, L., Benson, H.L., Vittal, R., Mickler, E.A., Presson, R., Fisher, A. Jo, Cummings, O.W., Heidler, K.M., Keller, M.R., Burlingham, W.J., Wilkes, D.S. · 2011 · American Journal of Transplantation
Cited by 154

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Obliterative bronchiolitis (OB) is the key impediment to the long-term survival of lung transplant recipients and the lack of a robust preclinical model precludes examining OB immunopathogenesis. In the current study, lungs from C57BL/10 H-2(b) mice that are MHC compatible, but minor histocompatability antigen incompatible, were transplanted into C57BL/6 mice. Histological features and cytokine profiles of OB were assessed. Moderate rejection (grade A3) developed by day 14, with evidence of OB at that time point. At 21 days, OB was present in 55% of grafts and moderate to severe rejection (grade A3-A4) was present in all mice. At 28 days, OB was present in 44% of mice and severe rejection (grade A4) was present in all. IL-17A, but not IL-17F, splenic mRNA transcripts and serum protein levels were increased only in mice that developed OB, whereas IL-10 transcripts and protein were increased only in non-OB mice. Neutralizing IL-17 prevented OB, down regulated acute rejection, and upregulated systemic IL-10. Collectively, these data show that transplantation of minor histoincompatible lungs from C57BL/10 mice into C57BL/6 mice results in a highly reproducible preclinical model of OB. In addition, these data indicate that neutralizing IL-17A or augmenting IL-10 could be therapeutic interventions to prevent OB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-6143.2011.03482.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent

    Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730 · cited 1×

    “Since OB is a fibrotic lesion, then data showing IL-17A blockade prevents OB are consistent with studies of nontransplant-related lung disease that showed blocking IL-17A prevented fibrosis (31).”
    Result

Show all 1 references

Cited by

See all 154

Metadata

Authors
Fan, L., Benson, H. L., Vittal, R., Mickler, E. A., Presson, R., Fisher, A. J., Cummings, O. W., Heidler, K. M., Keller, M. R., Burlingham, W. J., & Wilkes, D. S.
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2011-05
Volume
11
Issue
5
Pages
911-922
ISSN
1600-6135 (ISSN-L)
OpenAlex
W1602738207
Cited by
154
References
1
FWCI
18.68
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neutralizing IL-17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation. https://app.cochat.ai/papers/10.1111/j.1600-6143.2011.03482.x
The paper
Fan, L., Benson, H. L., Vittal, R., Mickler, E. A., Presson, R., Fisher, A. J., Cummings, O. W., Heidler, K. M., Keller, M. R., Burlingham, W. J., & Wilkes, D. S. (2011). Neutralizing IL-17 Prevents Obliterative Bronchiolitis in Murine Orthotopic Lung Transplantation. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2011.03482.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.